Garamycin® Ophthalmic Solution Now Available from Fera Pharmaceuticals

NEW YORK--(BUSINESS WIRE)-- Fera Pharmaceuticals announced the launch today of Garamycin (gentamicin sulfate) Ophthalmic Solution USP.

Garamycin Ophthalmic Solution, a broad spectrum anti-infective, is indicated for the treatment of ocular bacterial infections such as conjunctivitis, keratitis and blepharitis.

Garamycin is a trusted brand name and the product is a favorite among physicians who are looking for a single ingredient anti-infective ophthalmic solution.

About Fera Pharmaceuticals, LLC

Fera Pharmaceuticals is a privately held company. The company goal is to realize opportunities via acquisitions, in-licensing, developing and marketing abbreviated new drug applications (ANDAs), new drug applications (NDAs) and 505(b)(2) NDA products. For more information visit

Garamycin is a registered trademark of Fera Pharmaceuticals.


Fera Pharmaceuticals, LLC
Susan McDougal, 516-277-1450
[email protected]

KEYWORDS:   United States  North America  New York

INDUSTRY KEYWORDS:   Health  Hospitals  Infectious Diseases  Optical  Pharmaceutical  General Health